83602-39-5
基本信息
环胞霉素B
环孢霉素H
环孢菌素 H
环孢菌素杂质H
环孢素H, 来源于小单孢菌
环[L-丙氨酰-D-丙氨酰-N-甲基-L-亮氨酰-N-甲基-L-亮氨酰-N-甲基-L-缬氨酰-3-羟基-N,4-二甲基-L-2-氨基-6-辛烯酰-L-2-氨基丁酰-N-甲基甘氨酰-N-甲基-L-亮氨酰-L-缬氨酰-N-甲基-L-亮氨酰]
CYCLOSPORIN H
Cyclosporin H, >=95%
Cyclosporine IMpurity-H
5-(N-Methyl-D-valine)cyclosporin A
Cyclosporin H, froM MicroMonospora
5-(N-Methyl-D-valine)cyclosporine A
Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-D-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl]
Cyclo[L-alanyl-D-alanyl-N-Methyl-L- leucyl-N-Methyl-L-leucyl-N-Methyl-D-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-diMethyl-L-2-aMinooctanoyl-L-2-aMinobutanoyl-N-Methylglycyl-N-Methyl-L-leucyl-L-valyl-N-Methyl-L-leucyl]
物理化学性质
| 熔点 | 148-151°C |
| 沸点 | 1293.8±65.0 °C(Predicted) |
| 密度 | 1.016±0.06 g/cm3(Predicted) |
| 储存条件 | -20°C |
| 储存条件 | -20°C冷冻 |
| 溶解度 | 氯仿(微溶)、甲醇(微溶、加热、超声处理) |
| 酸度系数(pKa) | 13.32±0.70(Predicted) |
| 形态 | 粉末 |
| 颜色 | 白色至米色 |
| 生物来源 | Tolypocladium inflatum |
| 旋光度 (Optical Rotation) | [α]/D -100 to -115°, c = 0.5 in methanol |
| 序列 | Cyclo[{Abu}-{Sar}-{N(Me)Leu}-Val-{N(Me)Leu}-Ala-{d-Ala}-{N(Me)Leu}-{N(Me)Leu}-{d-N(Me)Val}-{N(Me)Bmt(E)}] |
| InChIKey | BQQHPBPTWWXRMU-SXHXJWHLSA-N |
安全数据
| 危险性符号(GHS) | ![]() ![]() GHS07,GHS08 |
| 警示词 | 危险 |
| 危险性描述 | H302-H350-H360 |
| 防范说明 | P202-P264-P270-P280-P301+P312-P308+P313 |
| WGK Germany | WGK 3 |
| 海关编码 | 29420000 |
| 存储类别 | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
| 危险性类别 | Acute Tox. 4 Oral Carc. 1B Repr. 1B |
环孢菌素 H价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2026/09/15 | HY-P1122 | 环孢菌素 H Cyclosporin H | 83602-39-5 | 1 mg | 1236元 |
| 2026/09/15 | HY-P1122 | 环孢菌素 H Cyclosporin H | 83602-39-5 | 5mg | 3400元 |
| 2026/09/15 | HY-P1122 | 环孢菌素 H Cyclosporin H | 83602-39-5 | 10mg | 5450元 |
常见问题列表
The cyclic undecapeptide, cyclosporin H, is a potent inhibitor of formyl-Met-Leu-Phe (FMLP)-induced superoxide anion (O2-) formation in human neutrophils. Cyclosporin H inhibits FMLP binding in HL-60 membranes with a K i of 0.1 μM. Cyclosporin H inhibits activation by FMLP of high affinity GTPase (the enzymatic activity of alpha-subunits of heterotrimeric regulatory guanine nucleotide-binding proteins) in HL-60 membranes with a K i of 0.79 μM. Cyclosporin H inhibits the stimulatory effects of FMLP on cytosolic Ca 2+ concentration ([Ca 2+ ]i), O2- formation, and beta-glucuronidase release with K i values of 0.08, 0.24, and 0.45 μM, respectively.
Cyclosporin H (5 mg/kg; i.p.; before LPS or HCl challenge) attenuats lung injury induced by LPS or HCl (a lung injurymodel).

